Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Genevieve Bouchard-Fortier

Showing results (1-10 of 28) with videos related to

Pageof 3
Sort By:
Current Treatment Options in Oncology|May 5, 2022
Immune Checkpoint Inhibitors for the Treatment of Gestational Trophoblastic Neoplasia: Rationale, Effectiveness, and Future FertilityLina Salman, Genevieve Bouchard-Fortier, Allan Covens
Gynecologic Oncology|December 18, 2021
Low incidence of venous thromboembolism after gynecologic oncology surgery: Who is at greatest risk?Brenna E Swift, Azusa Maeda, Genevieve Bouchard-Fortier
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|June 4, 2016
How Common Is the Growing Teratoma Syndrome in Patients With Ovarian Immature Teratoma?Julie My Van Nguyen, Genevieve Bouchard-Fortier, Sarah E Ferguson, et al.
Abdominal Radiology (New York)|February 10, 2023
Gestational trophoblastic disease: an updateTanya Chawla, Genevieve Bouchard-Fortier, Gulisa Turashvili, et al.
Radiology|April 1, 2025
Accuracy of Large Language Model-based Automatic Calculation of Ovarian-Adnexal Reporting and Data System MRI Scores from Pelvic MRI ReportsRajesh Bhayana, Ankush Jajodia, Tanya Chawla, et al.
Gynecologic Oncology|May 5, 2024
Hysterectomy versus chemotherapy for low-risk non-metastatic gestational trophoblastic neoplasia (GTN): A cost-effectiveness analysisCristina Mitric, Rashid K Sayyid, Neil E Fleshner, et al.
Journal of Surgical Oncology|November 24, 2025
Treatment Strategy and Residual Disease as Determinants of Survival in Stage IVB High-Grade Serous Ovarian Cancer: A Retrospective Cohort StudyAnouk Benseler, Adina Tanen, Taymaa May, et al.
Practical Radiation Oncology|November 5, 2025
Retained Surgical Sponge in the Pelvis From Magnetic Resonance Imaging-Guided Cervix BrachytherapyJuliet Maina, Anouk Benseler, Oleksandra Dzyubak, et al.
Gynecologic Oncology|February 6, 2021
The use of bevacizumab in the modern era of targeted therapy for ovarian cancer: A systematic review and meta-analysisShiru Liu, Lawrence Kasherman, Rouhi Fazelzad, et al.
Journal of Surgical Oncology|August 27, 2024
The impact of perioperative transfusions on the oncologic outcomes of patients with ovarian cancer: A population-based studyGenevieve Bouchard-Fortier, Lilian T Gien, Wing C Chan, et al.
Pageof 3

Showing results (1-10 of 28) with videos related to

Sort By:
Pageof 3
Current Treatment Options in Oncology|May 5, 2022
Immune Checkpoint Inhibitors for the Treatment of Gestational Trophoblastic Neoplasia: Rationale, Effectiveness, and Future FertilityLina Salman, Genevieve Bouchard-Fortier, Allan Covens
Gynecologic Oncology|December 18, 2021
Low incidence of venous thromboembolism after gynecologic oncology surgery: Who is at greatest risk?Brenna E Swift, Azusa Maeda, Genevieve Bouchard-Fortier
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|June 4, 2016
How Common Is the Growing Teratoma Syndrome in Patients With Ovarian Immature Teratoma?Julie My Van Nguyen, Genevieve Bouchard-Fortier, Sarah E Ferguson, et al.
Abdominal Radiology (New York)|February 10, 2023
Gestational trophoblastic disease: an updateTanya Chawla, Genevieve Bouchard-Fortier, Gulisa Turashvili, et al.
Radiology|April 1, 2025
Accuracy of Large Language Model-based Automatic Calculation of Ovarian-Adnexal Reporting and Data System MRI Scores from Pelvic MRI ReportsRajesh Bhayana, Ankush Jajodia, Tanya Chawla, et al.
Gynecologic Oncology|May 5, 2024
Hysterectomy versus chemotherapy for low-risk non-metastatic gestational trophoblastic neoplasia (GTN): A cost-effectiveness analysisCristina Mitric, Rashid K Sayyid, Neil E Fleshner, et al.
Journal of Surgical Oncology|November 24, 2025
Treatment Strategy and Residual Disease as Determinants of Survival in Stage IVB High-Grade Serous Ovarian Cancer: A Retrospective Cohort StudyAnouk Benseler, Adina Tanen, Taymaa May, et al.
Practical Radiation Oncology|November 5, 2025
Retained Surgical Sponge in the Pelvis From Magnetic Resonance Imaging-Guided Cervix BrachytherapyJuliet Maina, Anouk Benseler, Oleksandra Dzyubak, et al.
Gynecologic Oncology|February 6, 2021
The use of bevacizumab in the modern era of targeted therapy for ovarian cancer: A systematic review and meta-analysisShiru Liu, Lawrence Kasherman, Rouhi Fazelzad, et al.
Journal of Surgical Oncology|August 27, 2024
The impact of perioperative transfusions on the oncologic outcomes of patients with ovarian cancer: A population-based studyGenevieve Bouchard-Fortier, Lilian T Gien, Wing C Chan, et al.
Pageof 3